Franziska Brauneck

530 total citations
21 papers, 387 citations indexed

About

Franziska Brauneck is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Franziska Brauneck has authored 21 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Franziska Brauneck's work include Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (6 papers) and Immune cells in cancer (5 papers). Franziska Brauneck is often cited by papers focused on Immune Cell Function and Interaction (10 papers), CAR-T cell therapy research (6 papers) and Immune cells in cancer (5 papers). Franziska Brauneck collaborates with scholars based in Germany, United States and United Kingdom. Franziska Brauneck's co-authors include Walter Fiedler, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Jana Muschhammer, Friedrich Haag, Leticia Oliveira‐Ferrer, Eva Tolosa, Stephan Menzel and Hauke Stamm and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Franziska Brauneck

20 papers receiving 386 citations

Peers

Countries citing papers authored by Franziska Brauneck

Since Specialization

Citations

This map shows the geographic impact of Franziska Brauneck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franziska Brauneck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franziska Brauneck more than expected).

Fields of papers citing papers by Franziska Brauneck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franziska Brauneck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franziska Brauneck. The network helps show where Franziska Brauneck may publish in the future.

Co-authorship network of co-authors of Franziska Brauneck

This figure shows the co-authorship network connecting the top 25 collaborators of Franziska Brauneck. A scholar is included among the top collaborators of Franziska Brauneck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franziska Brauneck. Franziska Brauneck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells 2025 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), (unknown), (unknown), Michael Kruppa, (unknown), Jörg Krüger, Stephan Menzel, Friedrich Koch‐Nolte, (unknown), Katja Weisel, Carsten Bokemeyer, Jasmin Wellbrock, Walter Fiedler, Lennart Viezens, Franziska Brauneck	0
2	Murine Regulatory CD4+ T Cells Are Increased in Leukemic Spleens and Show High Co-Expression of Co-Regulatory Molecules CD39, CD73, PD1, and TIGIT 2024 ·International Journal of Molecular Sciences ·Jörg Krüger, Jasmin Wellbrock, (unknown), (unknown), Jana Muschhammer, Carsten Bokemeyer, (unknown), Walter Fiedler, (unknown), Franziska Brauneck	1
3	CD39 Is Predominantly Expressed in Adverse AML Patients and Blockade By a New Anti-CD39 Nanobody Increases Lysis of AML Blasts 2024 ·Blood ·Franziska Brauneck, Stefan Menzel, (unknown), (unknown), Walter Fiedler, Jasmin Wellbrock	1
4	The PTPN2/PTPN1 Inhibitor Abbv-CLS-484 Augments Immune Responses Against Leukemic Blasts and Impedes Leukemia Cell Proliferation in AML Alone and in Combination with Venetoclax 2024 ·Blood ·(unknown), Michael Kruppa, Jana Muschhammer, (unknown), Franziska Brauneck, (unknown), Jasmin Wellbrock, Walter Fiedler	1
5	Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction 2024 ·OncoImmunology ·(unknown), Leticia Oliveira‐Ferrer, Friedrich Koch‐Nolte, Stephan Menzel, (unknown), (unknown), (unknown), (unknown), Yi Ding, (unknown), Barbara Schmalfeldt, Carsten Bokemeyer, Walter Fiedler, Jasmin Wellbrock, Franziska Brauneck	12
6	Immunosuppressive M2 TAMs represent a promising target population to enhance phagocytosis of ovarian cancer cells in vitro 2023 ·Frontiers in Immunology ·Franziska Brauneck, Leticia Oliveira‐Ferrer, Jana Muschhammer, (unknown), (unknown), Friedrich Haag, Julian Schulze zur Wiesch, Yi Ding, (unknown), (unknown), Barbara Schmalfeldt, Carsten Bokemeyer, Walter Fiedler, Jasmin Wellbrock	10
7	The Clinical Significance of CD73 in Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Riekje Winzer, Eva Tolosa, Walter Fiedler, Franziska Brauneck	32
8	Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition 2022 ·Frontiers in Immunology ·(unknown), Andreas Walker, Franziska Brauneck, Vanessa Ditt, Sven Peine, Samuel Huber, Friedrich Haag, Claudia Beisel, Jörg Timm, Julian Schulze zur Wiesch	8
9	TIGIT blockade repolarizes AML-associated TIGIT⁺ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis 2022 ·Journal for ImmunoTherapy of Cancer ·Franziska Brauneck, (unknown), (unknown), Jana Muschhammer, (unknown), Pedro Avelar, Sophia Tsoka, Lars Bullinger, (unknown), Daniel J. Smit, Carsten Bokemeyer, (unknown), Jasmin Wellbrock, Friedrich Haag, Walter Fiedler	52
10	Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine 2022 ·Leukemia & lymphoma ·(unknown), Winfried Alsdorf, (unknown), Christine Wolschke, Franziska Brauneck, Carsten Bokemeyer, Walter Fiedler, (unknown), Panagiotis Karagiannis	1
11	Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer 2022 ·Cells ·(unknown), Jasmin Wellbrock, (unknown), Leticia Oliveira‐Ferrer, Yi Ding, Stephan Menzel, (unknown), (unknown), Barbara Schmalfeldt, Carsten Bokemeyer, Walter Fiedler, Franziska Brauneck	34
12	Increased frequency of TIGIT ⁺ CD73-CD8 ⁺ T cells with a TOX ⁺ TCF-1low profile in patients with newly diagnosed and relapsed AML 2021 ·OncoImmunology ·Franziska Brauneck, Friedrich Haag, (unknown), (unknown), Eva Tolosa, Anne Rissiek, Gabi Vohwinkel, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, (unknown), Walter Fiedler	28
13	Mebendazole Mediates Proteasomal Degradation of GLI Transcription Factors in Acute Myeloid Leukemia 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Jana Muschhammer, Hauke Stamm, Franziska Brauneck, (unknown), Carsten Bokemeyer, Karl N. Kirschner, Jasmin Wellbrock, Walter Fiedler	12
14	The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia 2021 ·Annals of Hematology ·Jasmin Wellbrock, (unknown), Jana Muschhammer, (unknown), (unknown), Franziska Brauneck, Carsten Bokemeyer, Eric Campeau, Walter Fiedler	4
15	Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma 2021 ·Frontiers in Medicine ·Franziska Brauneck, (unknown), Julian Schulze zur Wiesch, Katja Weisel, Lisa Leypoldt, Gabi Vohwinkel, (unknown), Carsten Bokemeyer, Jasmin Wellbrock, Walter Fiedler	30
16	Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML 2021 ·International Journal of Molecular Sciences ·Franziska Brauneck, (unknown), Jasmin Wellbrock, Julian Schulze zur Wiesch, Yinghui Duan, Tim Magnus, Carsten Bokemeyer, Friedrich Koch‐Nolte, Stephan Menzel, Walter Fiedler	46
17	Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis 2021 ·Blood ·Franziska Brauneck, (unknown), Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Friedrich Haag, (unknown), Walter Fiedler	3
18	Targeting the TIGIT-PVR immune checkpoint axis as novel therapeutic option in breast cancer 2019 ·OncoImmunology ·Hauke Stamm, Leticia Oliveira‐Ferrer, (unknown), Jana Muschhammer, (unknown), Franziska Brauneck, Roman Kischel, Volkmar Müller, Carsten Bokemeyer, Walter Fiedler, Jasmin Wellbrock	69
19	Mebendazole Mediates Its Anti-Leukemic Effects By Proteasomal Degradation of GLI Transcription Factors Via Inhibition of HSP70/90-Chaperone Activity in Acute Myeloid Leukemia in a Preclinical and Clinical Setting 2019 ·Blood ·(unknown), Hauke Stamm, Jana Muschhammer, (unknown), (unknown), (unknown), Franziska Brauneck, Jasmin Wellbrock, Walter Fiedler	3
20	Hydroxyurea Is Most Suitable for Cytoreduction of AML Prior to CD33/CD3 Bispecific BiTE® Antibody (AMG 330) Therapy: Uncompromised T-Cell Proliferation Ex-Vivo and CD33 Upregulation on AML Cells 2014 ·Blood ·Christina Krupka, Franziska Brauneck, Felix S. Lichtenegger, Peter Kufer, Roman Kischel, Gerhard Zugmaier, Thomas Köhnke, Torben Altmann, Stephanie Schneider, Michael Fiegl, Karsten Spiekermann, Angus M. Sinclair, Kathryn J. Newhall, Stanley R. Frankel, Patrick A. Baeuerle, Wolfgang Hiddemann, Gert Riethmüller, Marion Subklewe	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact